These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4041136)

  • 1. Comparison of the intraperitoneal and intravenous routes of cisplatin administration in an advanced ovarian cancer model of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Am J Obstet Gynecol; 1985 Sep; 153(1):106-11. PubMed ID: 4041136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The isolation and characterization of cisplatin-resistant rat ovarian cancer cells.
    Sekiya S; Oosaki T; Andoh S; Suzuki N; Nagao K; Takamizawa H
    Eur J Cancer Clin Oncol; 1988 May; 24(5):851-9. PubMed ID: 3169090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct diffusion of cis-diamminedichloroplatinum(II) in intraperitoneal rat tumors after intraperitoneal chemotherapy: a comparison with systemic chemotherapy.
    Los G; Mutsaers PH; van der Vijgh WJ; Baldew GS; de Graaf PW; McVie JG
    Cancer Res; 1989 Jun; 49(12):3380-4. PubMed ID: 2720692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell line.
    Sekiya S; Oosaki T; Andoh S; Suzuki N; Akaboshi M; Takamizawa H
    Eur J Cancer Clin Oncol; 1989 Mar; 25(3):429-37. PubMed ID: 2702997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Intraperitoneal cisplatin chemotherapy for ovarian cancer].
    Hayashi H; Nishii H; Ueda K; Kunitou S; Wada S; Takanashi H; Kobayashi S; Yasuda M
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2043-8. PubMed ID: 11791382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraperitoneal cisplatin and paclitaxel in ovarian cancer.
    Armstrong DK; Bundy B; Wenzel L; Huang HQ; Baergen R; Lele S; Copeland LJ; Walker JL; Burger RA;
    N Engl J Med; 2006 Jan; 354(1):34-43. PubMed ID: 16394300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surgically documented response to intraperitoneal cisplatin, cytarabine, and bleomycin after intravenous cisplatin-based chemotherapy in advanced ovarian adenocarcinoma.
    Piver MS; Lele SB; Marchetti DL; Baker TR; Emrich LJ; Hartman AB
    J Clin Oncol; 1988 Nov; 6(11):1679-84. PubMed ID: 3183700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo studies on the antitumor effect of cis-dichlorodiammineplatinum(II) against transplantable ovarian adenocarcinoma cells of the rat.
    Sekiya S; Iwasawa H; Takamizawa H
    Gynecol Oncol; 1983 Aug; 16(1):85-94. PubMed ID: 6684077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An experiment control study on the ovarian reserve function after cisplatin intraperitoneal or intravenous chemotherapy in rats model].
    Fan BZ; Xia H; Chu L; Tong XW
    Zhonghua Fu Chan Ke Za Zhi; 2017 Apr; 52(4):249-253. PubMed ID: 28441841
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antitumor effect of cis-diamminedichloroplatinum (II) against transplantable ovarian adenocarcinoma cells of the rat].
    Iwasawa H; Sekiya S; Takamizawa H
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1785-90. PubMed ID: 6892193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of a murine model for comparison of intravenous and intraperitoneal cisplatin in the treatment of microscopic ovarian cancer.
    Mannel RS; Stratton JA; Rettenmaier MA; Liao SY; DiSaia PJ
    Gynecol Oncol; 1988 Sep; 31(1):50-5. PubMed ID: 3410355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intraperitoneal administration of high doses of cisplatin in advanced ovarian carcinoma].
    Ptácková B; Kopecný J; Zatocil P; Anton M
    Cesk Gynekol; 1989 Mar; 54(2):106-9. PubMed ID: 2731237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intraperitoneal versus intravenous infusion of cis-platinum in advanced ovarian cancer--examination of pharmacokinetics].
    Shindo K; Oikawa N; Atsumi Y; Chida S; Tuburaya T; Yajima A
    Gan To Kagaku Ryoho; 1987 Mar; 14(3 Pt 1):639-44. PubMed ID: 3827260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simulation of Chemoperfusion Treatment for Abdominal Carcinomatosis.
    Bespalov VG; Belyaeva OA; Kireeva GS; Senchik KY; Stukov AN; Belyaev AM
    Bull Exp Biol Med; 2015 May; 159(1):81-4. PubMed ID: 26033596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental intraperitoneal administration of cisplatin-activated carbon for rat ovarian adenocarcinomas.
    Sugiyama T; Nishida T; Kumagai S; Ushijima K; Shinagawa A; Okina H; Tomioka Y; Kataoka A; Yakushiji M
    Kurume Med J; 1996; 43(1):33-9. PubMed ID: 8709557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ip cisplatin in patients with malignant ascites: pharmacokinetic evaluation and comparison with the iv route.
    Casper ES; Kelsen DP; Alcock NW; Lewis JL
    Cancer Treat Rep; 1983 Mar; 67(3):235-8. PubMed ID: 6682012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pharmacokinetic study of intraperitoneal chemotherapy with high-dose cisplatin for advanced ovarian cancer].
    Deng C; Huang R; Lian L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Mar; 31(3):159-62. PubMed ID: 8758790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of the pharmacokinetics of cisplatin administered by the intraperitoneal route in 2 dosages: 100 and 200 mg/m2].
    Canal P; Chatelut E; De Forni M; Chevreau C; Johnson N; Houin G; Bugat R
    Bull Cancer; 1989; 76(8):879-82. PubMed ID: 2620116
    [No Abstract]   [Full Text] [Related]  

  • 19. High intra-abdominal pressure enhances the penetration and antitumor effect of intraperitoneal cisplatin on experimental peritoneal carcinomatosis.
    Esquis P; Consolo D; Magnin G; Pointaire P; Moretto P; Ynsa MD; Beltramo JL; Drogoul C; Simonet M; Benoit L; Rat P; Chauffert B
    Ann Surg; 2006 Jul; 244(1):106-12. PubMed ID: 16794395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental technology of chemoperfusion treatment for abdominal carcinomatosis in ovarian cancer].
    Beliaeva OA; Bespalov VG; Senchik KIu; Kireeva GS; Stukov AN; Aristova VA; Ivantsov AO; Vyshinskaia EA; Maĭdin MA; Semënov AL; Aleksandrov VA; Beliaev AM
    Vopr Onkol; 2014; 60(1):71-9. PubMed ID: 24772620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.